Literature DB >> 21489644

India's growing participation in global clinical trials.

Yogendra K Gupta1, Biswa M Padhy.   

Abstract

Lower operational costs, recent regulatory reforms and several logistic advantages make India an attractive destination for conducting clinical trials. Efforts for maintaining stringent ethical standards and the launch of Pharmacovigilance Program of India are expected to maximize the potential of the country for clinical research.
Copyright © 2011. Published by Elsevier Ltd.

Mesh：

Year:  2011        PMID： 21489644     DOI： 10.1016/j.tips.2011.02.017

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


  14 in total

1.  Clinical Research Environment in India: Challenges and Proposed Solutions.

Authors:  Tal Burt; Pooja Sharma; Savita Dhillon; Mukul Manchanda; Sanjay Mittal; Naresh Trehan
Journal:  J Clin Res Bioeth       Date:  2014-11-01

2.  Compensation for clinical trial-related injury and death in India: challenges and the way forward.

Authors:  Yogendra Kumar Gupta; Arun Kumar Pradhan; Aman Goyal; Prafull Mohan
Journal:  Drug Saf       Date:  2014-12       Impact factor: 5.606

3.  An adverse drug reaction clinic: Breathing fresh life into the pharmacovigilance programme.

Authors:  Dick B S Brashier; Sushil Sharma
Journal:  J Pharmacol Pharmacother       Date:  2012-01

4.  GCP compliance and readability of informed consent forms from an emerging hub for clinical trials.

Authors:  Satish Chandrasekhar Nair; Halah Ibrahim
Journal:  Perspect Clin Res       Date:  2015 Apr-Jun

5.  Clinical trials in India: Where do we stand globally?

Authors:  Sandhiya Selvarajan; Melvin George; Suresh S Kumar; Steven Aibor Dkhar
Journal:  Perspect Clin Res       Date:  2013-07

Review 6.  Challenges in launching multinational oncology clinical trials in India.

Authors:  Kamal S Saini; Gaurav Agarwal; Ramesh Jagannathan; Otto Metzger-Filho; Monika L Saini; Khurshid Mistry; Raghib Ali; Sudeep Gupta
Journal:  South Asian J Cancer       Date:  2013-01

7.  Ethics Standards (HRPP) and Public Partnership (PARTAKE) to Address Clinical Research Concerns in India: Moving Toward Ethical, Responsible, Culturally Sensitive, and Community-Engaging Clinical Research.

Authors:  Tal Burt; Yogendra K Gupta; Nalin Mehta; Nagendra Swamy; Marjorie A Speers
Journal:  J Clin Res Bioeth       Date:  2014-09-07

8.  Clinical trials in oncology: Has India come of age?

Authors:  Subhash Desai; Abhishek Mahajan
Journal:  Indian J Med Paediatr Oncol       Date:  2015 Jul-Sep

9.  PARTAKE survey of public knowledge and perceptions of clinical research in India.

Authors:  Tal Burt; Savita Dhillon; Pooja Sharma; Danish Khan; Deepa Mv; Sazid Alam; Sarika Jain; Bhavana Alapati; Sanjay Mittal; Padam Singh
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

10.  Opinions and perceptions regarding the impact of new regulatory guidelines: A survey in Indian Clinical Trial Investigators.

Authors:  Rashmi Kadam; Sanghratna Borde; Sapna Madas; Aarti Nagarkar; Sundeep Salvi; Sneha Limaye
Journal:  Perspect Clin Res       Date:  2016 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.